Sort
326,823 grants matching “clinical trial”
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
$2,309,994Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2017 · CA
Discovery, Biology and Risk of Inherited Variants in Breast Cancer
$2,309,806David John Hunter · Harvard School Of Public Health · U19 · FY2013 · CA
Investigation of the Cortical Communication (CORTICOM) System
$2,309,654Nathan E Crone · Johns Hopkins University · UH3 · FY2021 · NS
Ebola Vaccine Development
$2,309,604Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Hepatobiology and Toxicology COBRE
$2,309,596Craig J McClain · University Of Louisville · P20 · FY2022 · GM
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
$2,309,363Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2024 · CA
Translational Immunopsychiatry Unit
$2,309,309Christopher Bartley · National Institute Of Mental Health · ZIA · FY2023 · MH
Cancer Center Support Grant
$2,309,270Boris Pasche · Wake Forest University Health Sciences · P30 · FY2019 · CA
ProTECT III
$2,309,246David W Wright · Emory University · U01 · FY2009 · NS
Look AHEAD: Action for Health in Diabetes
$2,309,201Mark Andrew Espeland · Wake Forest University Health Sciences · U01 · FY2010 · DK
Support for Biomedical and Clinical Information Services - OPTION YEAR 2
$2,309,200Matthew Perry · Icf, Inc., Llc · N03 · FY2011 · LM
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$2,309,154Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Development of a MT-stabilizing agent for the treatment of tauopathies
$2,309,108Conor Caffrey · University Of California, San Diego · U01 · FY2024 · AG
Hopkins Center for Eliminate Cardiovascular Health Disparities
$2,308,906Lisa A Cooper · Johns Hopkins University · P50 · FY2013 · HL
Ibudilast Phase II trial in progressive MS
$2,308,268Robert J. Fox · Cleveland Clinic Lerner Com-Cwru · U01 · FY2016 · NS
Translational development of new agents alone and in combination to combat Gram-negative pathogens important in Ventilator- Associated Bacterial Pneumonia: Leveraging the Gram-negative toolbox that is
$2,308,174George Louis Drusano · University Of Florida · P01 · FY2024 · AI
UCLA Los Angeles Brazil AIDS Consortium
$2,307,974Yvonne J Bryson · University Of California Los Angeles · U01 · FY2011 · AI
COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)
$2,307,858Tom Denny · Duke University · N01 · FY2021 · AI
University of New Mexico Cancer Center Support Grant
$2,307,793Alan E Tomkinson · University Of New Mexico Health Scis Ctr · P30 · FY2021 · CA
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,307,769Marschall S. Runge · Univ Of North Carolina Chapel Hill · UL1 · FY2011 · RR
Mammalian Hibernation Research- A Path Towards a Center for Transformative Research in Metabolism
$2,307,703Kelly L Drew · University Of Alaska Fairbanks · P20 · FY2021 · GM
Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
$2,307,686Christoph Hornik · Duke University · R33 · FY2022 · HL
Mammalian Hibernation Research- A Path Towards a Center for Transformative Research in Metabolism
$2,307,661Kelly L Drew · University Of Alaska Fairbanks · P20 · FY2022 · GM
Development of Novel Therapeutic Strategies in Human Leukemias
$2,307,647Benjamin Levine Ebert · Brigham And Women'S Hospital · P01 · FY2014 · CA
Mammalian Hibernation Research- A Path Towards a Center for Transformative Research in Metabolism
$2,307,616Kelly L Drew · University Of Alaska Fairbanks · P20 · FY2023 · GM